1276202

Novartis Pharmaceuticals Corporation — FEI 2210396

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Hanover, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)